This fall: 2026-02-17 Earnings Abstract
EPS of $1.70 beats by $0.09
| Income of $107.11M (17.52% Y/Y) beats by $1.98M
Krystal Biotech, Inc. (KRYS) This fall 2025 Earnings Name February 17, 2026 8:30 AM EST
Firm Contributors
Stephane Paquette – Vice President of Company Growth
Krish Krishnan – Founder, Chairman, President & CEO
Christine Wilson – Head of U.S. Gross sales & Advertising
Laurent Goux – Senior VP & GM of Europe
Suma Krishnan – Founder, President of R&D and Director
Kathryn Romano – Government VP & Chief Accounting Officer
Convention Name Contributors
Jiale Track – Jefferies LLC, Analysis Division
Samantha Corwin – William Blair & Firm L.L.C., Analysis Division
Alec Stranahan – BofA Securities, Analysis Division
Yigal Nochomovitz – Citigroup Inc., Analysis Division
Joshua Fleishman – TD Cowen, Analysis Division
Gavin Clark-Gartner – Evercore ISI Institutional Equities, Analysis Division
Presentation
Operator
Thanks for standing by, and welcome to the Krystal Biotech 4Q 2025 Convention Name. [Operator Instructions] As a reminder, immediately’s convention is being recorded. I’d now like handy the convention over to your host, Stephane Paquette, Vice President of Company Growth.
Stephane Paquette
Vice President of Company Growth
Good morning, and thanks all for becoming a member of immediately’s name. Earlier immediately, we launched our monetary outcomes for the fourth quarter and full 12 months of 2025. The press launch is accessible on our web site at www.krystalbio.com. We additionally filed our earnings 8-Ok and 10-Ok with the SEC earlier immediately. Becoming a member of me immediately will likely be Krish Krishnan, Chairman and Chief Government Officer; Suma Krishnan, President of Analysis and Growth; Christine Wilson, Senior Vice President and Head of U.S. Industrial; Laurent Goux, Senior Vice President and Common Supervisor for Europe; and Kate Romano, Chief Accounting Officer.
This convention name will and our responses to questions could include forward-looking statements. You’re cautioned to not depend on these forward-looking statements, that are primarily based on present expectations utilizing the data accessible as of the date of this name and are topic to sure
